02:09:01 | ◀︎ | UK financial regulation overhauled | |
03:06:10 | ◀︎ | No house survey 'is false economy' | |
08:07:44 | ◀︎ | Japanese business sentiment improves | |
08:07:44 | ◀︎ | China factory pace at 11-month high | |
08:07:44 | ◀︎ | India rejects Novartis patent plea | |
09:51:42 | ◀︎ | Welfare reforms fair - Duncan Smith | |
10:37:11 | ◀︎ | Lord Turner to join Soros think tank | |
17:43:51 | ◀︎ | Campaigners hail Novartis ruling | |
17:46:05 | ◀︎ | Jobs lost as historic mill closes | |
22:47:01 | ◀︎ | Cyprus crisis: No Russian bailout | |
23:05:31 | ◀︎ | Apple apologises to China customers |
זמני השבת
עיר | כניסה | יציאה |
---|---|---|
ירושלים | 18:03 | 19:13 |
תל אביב | 18:17 | 19:15 |
חיפה | 18:09 | 19:15 |
באר שבע | 18:20 | 19:16 |
הכותרות שעניינו הכי הרבה גולשים בדף זה
01/04/13 02:09
0% מהצפיות
מאת BBC News
The UK's banking regulator, the Financial Services Authority, is abolished and replaced with two successor organisations.
01/04/13 03:06
0% מהצפיות
מאת BBC News
More families are shunning full building surveys so they can raise enough cash to buy a home, but this can lead to big repair bills later, surveyors say.
01/04/13 08:07
0% מהצפיות
מאת BBC News
Japanese business sentiment improves in the January to March quarter, the Bank of Japan's Tankan survey indicates.
01/04/13 08:07
0% מהצפיות
מאת BBC News
Chinese manufacturing activity increases at its fastest pace in 11 months during March, indicating that an economic recovery is continuing.
01/04/13 08:07
0% מהצפיות
מאת BBC News
India's Supreme Court rejects a plea by Swiss company Novartis to patent an updated version of its cancer drug, Glivec.
01/04/13 09:51
0% מהצפיות
מאת BBC News
Changes to the UK's welfare system are fair, Work and Pensions Secretary Iain Duncan Smith insists, as some of the changes come into effect.
01/04/13 10:37
0% מהצפיות
מאת BBC News
Lord Turner, head of the now-disbanded Financial Services Authority, is to join a US think tank co-founded by billionaire investor George Soros.
01/04/13 17:43
0% מהצפיות
מאת BBC News
Healthcare campaigners hail India's rejection of a patent bid by Swiss company Novartis for its cancer drug, Glivec, amid industry criticism.